{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:53:04Z","timestamp":1794109984223,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.schres.2021.11.023","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T12:30:52Z","timestamp":1637843452000},"page":"34-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study"],"prefix":"10.1016","volume":"239","author":[{"given":"Bernardo","family":"Carpiniello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Manchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Tusconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2021.11.023_bb0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10673229.2012.747804","article-title":"Remission in schizophrenia: critical and systematic review","volume":"20","author":"Alaqeel","year":"2012","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0010","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/0269881103174013","article-title":"The Barnes akathisia rating scale - revisited","author":"Barnes","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2021.11.023_bb0020","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.pnpbp.2008.06.008","article-title":"Comparative remission rates of schizophrenic patients using various remission criteria","volume":"32","author":"Beitinger","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2021.11.023_bb0025","first-page":"243","article-title":"Incidence and characteristics of remission in schizophrenic patients: analysis of the results of a three year SOHO study in Italy (Schizophrenia outpatients health Outcomes)","volume":"14","author":"Brugnoli","year":"2008","journal-title":"Ital. J. Psychopathol."},{"key":"10.1016\/j.schres.2021.11.023_bb0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/schbul\/8.3.470","article-title":"Measurement of premorbid adjustment in chronic schizophrenia","volume":"8","author":"Cannon-Spoor","year":"1982","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.11.023_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/576369","article-title":"Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study","volume":"2012","author":"Carpiniello","year":"2012","journal-title":"Schizophr. Res. Treatment"},{"key":"10.1016\/j.schres.2021.11.023_bb0040","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/schbul\/sbp007","article-title":"Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years","volume":"36","author":"Cassidy","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.11.023_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.schres.2018.08.022","article-title":"Ten-year follow up of patients with first-episode schizophrenia spectrum disorder from an early intervention service: predictors of clinical remission and functional recovery","volume":"204","author":"Chan","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.11.023_bb0050","doi-asserted-by":"crossref","first-page":"e1046","DOI":"10.4088\/JCP.13m08355","article-title":"Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study","volume":"74","author":"Chang","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.schres.2008.12.004","article-title":"Remission in schizophrenia: results from a 1-year follow-up observational study","volume":"108","author":"Ciudad","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.11.023_bb0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jagp.2013.09.004","article-title":"Longitudinal study of remission among older adults with schizophrenia spectrum disorder","volume":"22","author":"Cohen","year":"2014","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.comppsych.2008.08.010","article-title":"Remission in schizophrenia: analysis in a naturalistic setting","volume":"50","author":"Eberhard","year":"2009","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0070","first-page":"114","article-title":"The concepts of remission and recovery in schizophrenia","volume":"24","author":"Emsley","year":"2011","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0075","series-title":"Structured Clinical Interview for DSM-IV (SCID-I) (User\u2019s Guide and Interview) Research Version","author":"First","year":"1997"},{"key":"10.1016\/j.schres.2021.11.023_bb0080","series-title":"Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)","author":"First","year":"1997"},{"issue":"6","key":"10.1016\/j.schres.2021.11.023_bb0085","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.eurpsy.2011.01.011","article-title":"No gender differences in social outcome in patients suffering from schizophrenia","volume":"27","author":"Galderisi","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamapsychiatry.2017.4607","article-title":"Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis","volume":"75","author":"Galderisi","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/wps.20700","article-title":"The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients","volume":"19","author":"Galderisi","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0100","series-title":"ECDEU Assessment Manual for Psychopharmacology - Revised","first-page":"223","article-title":"Dosage record and treatment emergent symptoms scale (DOTES)","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2021.11.023_bb0105","series-title":"ECDEU Assessment Manual for Psychopharmacology - Revised","first-page":"534","article-title":"Abnormal Involuntary Movement Scale (AIMS)","author":"Guy","year":"1976"},{"issue":"Suppl. 107","key":"10.1016\/j.schres.2021.11.023_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: A simple instrument to measure the diversity of symptoms present in schizophrenia","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2021.11.023_bb0115","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1192\/bjp.bp.110.082065","article-title":"Cross-national clinical and functional remission rates: worldwide schizophrenia outpatient health outcomes (W-SOHO) study","volume":"199","author":"Haro","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.schres.2009.07.004","article-title":"The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study","volume":"115","author":"Helldin","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.11.023_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291700050182","article-title":"A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity","volume":"13","author":"Hogan","year":"1983","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2021.11.023_bb0130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4088\/JCP.14m09320","article-title":"Prognostic subgroups for remission, response, and treatment continuation in the clinical antipsychotic trials of intervention effectiveness (CATIE) trial","volume":"76","author":"Jakubovski","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2017.09.007","article-title":"What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: an exploratory follow-up study","volume":"195","author":"Johansson","year":"2018","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2021.11.023_bb0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.eurpsy.2011.01.012","article-title":"Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia","volume":"27","author":"Karow","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.11.023_bb0150","series-title":"Versione Italiana a cura di Migone P","article-title":"The structured clinical interview for positive and negative syndromes of schizophrenia","author":"Kay","year":"1999"},{"key":"10.1016\/j.schres.2021.11.023_bb0155","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.4088\/JCP.v67n1104","article-title":"Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia","volume":"67","author":"Lambert","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.31887\/DCNS.2010.12.3\/mlambert","article-title":"Remission in schizophrenia: validity, frequency, predictors, and patients\u2019 perspective 5 years later","volume":"12","author":"Lambert","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.schres.2021.11.023_bb0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2019.04.025","article-title":"Course and predictors of symptomatic remission in late-life schizophrenia: a 5-year follow-up study in a dutch psychiatric catchment area","volume":"209","author":"Lange","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.11.023_bb0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.13049su1c.02","article-title":"Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application","volume":"75","author":"Leucht","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0175","doi-asserted-by":"crossref","DOI":"10.1055\/s-2006-949513","article-title":"The concepts of remission and recovery in schizophrenia","author":"Leucht","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0180","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.comppsych.2013.12.011","article-title":"Predictors of symptomatic remission in patients with first-episode schizophrenia: a 16 years follow-up study","volume":"55","author":"Marchesi","year":"2014","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.euroneuro.2012.02.008","article-title":"DAI-10 is as good as DAI-30 in schizophrenia","volume":"22","author":"Nielsen","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2021.11.023_bb0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.schres.2008.11.007","article-title":"Recovery in the outpatient setting: 36-month results from the schizophrenia outpatients health outcomes (SOHO) study","volume":"108","author":"Novick","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.11.023_bb0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-244X-7-35","article-title":"Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings","volume":"7","author":"Opler","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0200","first-page":"3:60","article-title":"Valutazione dimensionale della sintomatologia schizofrenica. Validazione della versione italiana della scala per la valutazione Dei sintomi positivi e negativi (PANSS)","volume":"1","author":"Pancheri","year":"1995","journal-title":"Giorn Ital Psicopat"},{"key":"10.1016\/j.schres.2021.11.023_bb0205","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.psychres.2013.08.022","article-title":"Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders","volume":"210","author":"Pinna","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2021.11.023_bb0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1471-244X-13-235","article-title":"Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders","volume":"13","author":"Pinna","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.scog.2014.11.001","article-title":"Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances","volume":"1","author":"Pinna","year":"2014","journal-title":"Schizophr. Res. Cognit."},{"key":"10.1016\/j.schres.2021.11.023_bb0220","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/hup.1067","article-title":"Remission in schizophrenia: one-year italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder","volume":"24","author":"Rossi","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2021.11.023_bb0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1176\/appi.ajp.163.3.433","article-title":"Prognostic variables at intake and long-term level of function in schizophrenia","volume":"163","author":"Siegel","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.11.023_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2021.11.023_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0447.2005.00659.x","article-title":"Standardized remission criteria in schizophrenia","author":"Van Os","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2021.11.023_bb0240","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13094","article-title":"Very long-term outcome of schizophrenia","author":"Volavka","year":"2018","journal-title":"Int. J. Clin. Pract."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421004448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421004448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:44:06Z","timestamp":1760298246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996421004448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":48,"alternative-id":["S0920996421004448"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2021.11.023","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2021.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}